Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide

H. Madsen, T. P. Enggaard, L. L. Hansen, N. A. Klitgaard, K. Brøsen

Research output: Contribution to journal › Journal article › Research › peer-review

Original language	English
Journal	Clinical Pharmacology & Therapeutics
Volume	69
Issue number	1
Pages (from-to)	41-47
ISSN	0009-9236
DOIs	https://doi.org/10.1067/mcp.2001.112689
Publication status	Published - 2001

Documents & Links

@article{ba33e990ba9511dc9626000ea68e967b,

title = "Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide",

author = "H. Madsen and Enggaard, {T. P.} and Hansen, {L. L.} and Klitgaard, {N. A.} and K. Br{\o}sen",

year = "2001",

doi = "10.1067/mcp.2001.112689",

language = "English",

volume = "69",

pages = "41--47",

journal = "Clinical Pharmacology & Therapeutics",

issn = "0009-9236",

publisher = "Wiley",

number = "1",

}

TY - JOUR

T1 - Fluvoxamine inhibits the CYP2C9 catalyzed biotransformation of tolbutamide

AU - Madsen, H.

AU - Enggaard, T. P.

AU - Hansen, L. L.

AU - Klitgaard, N. A.

AU - Brøsen, K.

PY - 2001

Y1 - 2001

U2 - 10.1067/mcp.2001.112689

DO - 10.1067/mcp.2001.112689

M3 - Journal article

SN - 0009-9236

VL - 69

SP - 41

EP - 47

JO - Clinical Pharmacology & Therapeutics

JF - Clinical Pharmacology & Therapeutics

IS - 1

ER -